Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ARIDIS-PHARMACEUTICALS-IN-45272048/news/Aridis-gibt-den-Abschluss-der-Patientenrekrutierung-fur-die-globale-Phase-3-Uberlegenheitsstudie-A-41931756/?utm_source=whatsapp&utm_medium=social&utm_campaign=share